Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
07/1999
07/07/1999EP0927183A1 Spirocyclic metalloprotease inhibitors
07/07/1999EP0927038A1 P1, p4-dithio-p2,p3-monochloromethylene 5', 5'''-diadenosine p1, p4-tetraphosphate as antithrombotic agent
07/07/1999EP0927035A1 Thrombin inhibitors
07/07/1999CN1221621A Blood platelet regenerating pills and its prepn. method
07/06/1999US5919895 Secretion of hirudin derivatives
07/06/1999US5919818 Tocotrienols and tocotrienol-like compounds and methods for their use
07/06/1999US5919765 Inhibitors of factor XA
07/06/1999US5919762 Conjugates of hirudin and lipophilic compounds
07/06/1999US5919660 Human requiem
07/06/1999CA2004764C Ancrod proteins, their preparation and use
07/06/1999CA1340633C Method and therapeutic compositions for the treatment of myocardial infarction
07/01/1999WO1999032477A1 Ortho-anthranilamide derivatives as anti-coagulants
07/01/1999WO1999032454A1 Nitrogen containing heteroaromatics with ortho-substituted p1's as factor xa inhibitors
07/01/1999WO1999032131A1 Pharmaceutical composition comprising ticlopidine and ginkgo biloba extract
07/01/1999DE19757983A1 Thermodynamisch stabile Form von (r)-3[[(4-Fluorophenyl)sulfonyl]amino]-1,2,3,4-tetrahydro-9H-carbazol-0-propansäure (Ramatroban) Thermodynamically stable form of (R) -3 [[(4-fluorophenyl) sulfonyl] amino] -1,2,3,4-tetrahydro-9H-carbazol-0-propanoic acid (ramatroban)
07/01/1999CA2315070A1 Ortho-anthranilamide derivatives as anti-coagulants
07/01/1999CA2314401A1 Nitrogen containing heteroaromatics with ortho-substituted p1's as factor xa inhibitors
06/1999
06/30/1999EP0926237A2 Nucleic acid constructs for gene therapy, whose activity is influenced by inhibitors of cyclin-dependent kinases
06/30/1999EP0926236A1 Binding partners for inhibitors of cyclin-dependent kinases and their use for inhibitor screening, diagnosis or therapy
06/30/1999EP0925294A1 Substituted 2(2,6-dioxopiperidin-3-yl)phthalimides and -1-oxoisoindolines and method of reducing tnf-alpha levels
06/30/1999EP0925071A1 Muc-1 as an immunosuppressive therapeutic agent for the treatment of inflammatory and autoimmune conditions
06/30/1999EP0701606A4 Method of enhancing thrombolysis
06/30/1999CN1221344A Extractable compounds and method for making and using the same
06/30/1999CN1043884C New substituted azacylobutanone, preparation method and medicinal use thereof
06/29/1999US5917034 Antithrombotic n-amidinopiperidine and benzamidine derivatives
06/29/1999US5916888 Imidazo 1,5A!pyridine derived serine protease inhibitors
06/29/1999US5916792 Jak3 plays a role in the growth factor modulated differentiation/proliferation of the stem/progenitor cells.
06/29/1999US5916773 Recombinant production of fusion proteins comprising erythropoietin and GM-CSF components
06/29/1999US5916555 Pharmaceutical composition for treatment of diabetes
06/24/1999WO1999031138A1 Method for preparing by filtration a virally secure factor viii solution
06/24/1999WO1999031126A1 Cyclopeptide derivatives with integrin inhibitor properties
06/24/1999WO1999031116A1 Human dendriac and brainiac-3
06/24/1999WO1999031092A1 Benzamine derivatives
06/24/1999WO1999030670A2 Methods of treatment using novel ligands of the neuropeptide receptor hfgan72 and agonists or antagonists thereof
06/24/1999CA2314379A1 Human dendriac and brainiac-3
06/24/1999CA2313651A1 Benzamine derivatives
06/23/1999EP0924519A2 Process for determining of a dosage regime for thrombin inhibitors
06/23/1999EP0923582A1 Substituted 6,5-hetero-bicyclic derivatives
06/23/1999EP0923555A1 Carboxamide derivatives of pyrrolidine, piperidine and hexahydroazepine for the treatment of thrombosis disorders
06/23/1999EP0923553A1 Stable non-hygroscopic crystalline form of n- n-n-(4-(piperidin-4-yl)butanoyl)-n-ethylglycyl] compounds
06/23/1999EP0923530A1 Inhibition of matrix metalloproteases by substituted biaryl oxobutyric acids
06/23/1999EP0923529A1 Subsitute 4-arylbutyric acid derivatives as matrix metalloprotease inhibitors
06/23/1999EP0923377A1 Therapeutic uses for an aminosterol compound
06/23/1999EP0923373A1 Il-8 receptor antagonists
06/23/1999EP0502117B1 Pharmaceutical compositions comprising polymers with alkyl- or heteroalkyl-aryl backbone
06/23/1999CN1220606A P1, P4-dithio-P2,P3-monochloromethylene 5',5'-diadenosine P1,P4-tetraphosphate as antithrombotic agent
06/23/1999CN1220150A Tongmai shuluo vessel-freeing injection and its preparing technology
06/22/1999US5914352 Methods for the use of stabilized fluorocarbon emulsions
06/22/1999US5914345 Treatment with stimulus to induce altered levels of stress response or hear shock proteins
06/22/1999US5914319 Antithrombotic agents
06/22/1999US5914315 Isolated amino acid sequences encoding a kunitz-type inhibitor; anticoagulants for treating deep vein thrombosis
06/22/1999US5914118 Multi-layered drug containing film preparation having powder adhesive thereon
06/22/1999US5914106 Interleukin-6 receptor agonists
06/22/1999CA1340608C Alkoxy-4(1h)-pyridone derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
06/20/1999CA2255143A1 Binding partners for inhibitors of cyclin-dependent kinases and their use for searching for inhibitors and for the diagnosis or therapy of a disease
06/20/1999CA2255141A1 Nucleic acid constructs for gene therapy whose activity is affected by inhibitors of cyclin-dependent kinases
06/17/1999WO1999029848A1 Novel vectors and genes exhibiting increased expression
06/17/1999WO1999029838A1 Fibrinogen-converting enzyme hybrids
06/17/1999WO1999029734A1 Dextran derivatives, preparation method and applications as medicine with specific biological action
06/17/1999WO1999029693A1 Imidazonaphthyridines and their use in inducing cytokine biosynthesis
06/17/1999WO1999029664A1 New compounds
06/17/1999WO1999029338A1 Fibrinolytic inhibitor for sealant
06/17/1999WO1999029316A1 Pharmaceutical compositions containing an omega-3 fatty acid oil
06/17/1999WO1999029173A1 Composition useful for providing one-step surgical preparation and drape
06/17/1999WO1999017742A3 Taste masked formulations
06/17/1999DE19755800A1 Cyclopeptidderivate Cyclopeptide derivatives
06/17/1999DE19755268A1 Benzamidinderivate Benzamidine derivatives
06/17/1999CA2313405A1 Fibrinolytic inhibitor for sealant
06/17/1999CA2312476A1 Fibrinogen-converting enzyme hybrids
06/17/1999CA2312291A1 Novel vectors and genes exhibiting increased expression
06/17/1999CA2309686A1 Composition useful for providing one-step surgical preparation and drape
06/16/1999EP0922107A1 Human kallikrein
06/16/1999EP0922105A2 Infectious papillomavirus pseudoviral particles
06/16/1999EP0922100A2 Secreted proteins and polynucleotides encoding them
06/16/1999EP0922054A1 Anticoagulant peptidyl-arginine aldehyde derivatives
06/16/1999EP0922045A1 Bicyclic pyrimidine derivatives and their use as anti-coagulants
06/16/1999EP0922039A1 Cyclic carbamates and isoxazolidines as iib/iiia antagonists
06/16/1999EP0921815A1 Therapeutic uses of humanized antibodies against alpha-4 integrin
06/16/1999EP0684830B1 Inhibitors of thrombosis
06/16/1999CN1219939A Method and apparatus for preparing acellular red blood cell substitute
06/16/1999CN1219936A New triazolopurines, method of preparing them and their use as drugs
06/16/1999CN1219933A Novel oxazolidine derivatives, process for their production and medicaments containing them
06/16/1999CN1219932A Aromatic amidine derivatives useful as selective thrombin inhibitors
06/16/1999CN1043647C Peptide compound
06/16/1999CN1043608C Improvements in or relating to benzothiophenes
06/15/1999US5912360 Dioxolane intermediates
06/15/1999US5912123 Detection of the leptin receptor in reproductive organs and methods for regulating reproductive biology
06/15/1999US5912005 Methods of use of uncoated gel particles
06/10/1999WO1999028351A1 Persulfated chondroitin sulfates, process for producing the same, and anticoagulants containing the same as the active ingredient
06/10/1999WO1999028348A1 Oxygen-transporting albumin-based blood replacement composition and blood volume expander
06/10/1999WO1999028346A1 Erythropoietin with high specific activity
06/10/1999WO1999027962A1 Use of a fibrinogen receptor-antagonist for preventing disseminated intravascular coagulation
06/10/1999WO1999027930A1 Thrombin inhibitors
06/10/1999WO1999027912A1 Porous hydroxyapatite particles as carriers for drug substances
06/10/1999WO1999027890A2 A process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs
06/10/1999WO1998040080A9 Oxyalkylene phosphate compounds and uses thereof
06/10/1999DE19753383A1 Verwendung von Abciximab zur Behandlung von Mikrozirkulationsstörungen Use of abciximab for treatment of microcirculatory disorders
06/10/1999CA2312824A1 Use of a fibrinogen receptor-antagonist for preventing disseminated intravascular coagulation
06/10/1999CA2311780A1 Porous hydroxyapatite particles as carriers for drug substances
06/10/1999CA2309810A1 Erythropoietin with high specific activity
1 ... 538 539 540 541 542 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 ... 671